Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Esser

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Journal of Immunological Methods|February 2, 2006
A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheresSonela A Schlottmann, Neil Jain, Narendra Chirmule, et al.
The Lancet. Respiratory Medicine|December 15, 2022
Cardiac and vascular serious adverse events following tixagevimab-cilgavimab - Author's replySheetal Maselkar, Alexandre Kiazand, Alison Templeton, et al.
Human Vaccines & Immunotherapeutics|June 19, 2018
Generalized ROC methods for immunogenicity data analysis of vaccine phase I studies in a seropositive populationLi Yu, Mark T Esser, Judith Falloon, et al.
Journal of Immune Based Therapies and Vaccines|April 22, 2005
Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvantWanda Ruiz, William L McClements, Kathrin U Jansen, et al.
Expert Review of Vaccines|May 21, 2017
Passive and active immunization against respiratory syncytial virus for the young and oldTonya Villafana, Judith Falloon, M Pamela Griffin, et al.
Human Vaccines|April 5, 2008
Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11Judith F Smith, Rose Kowalski, Mark T Esser, et al.
Clinical and Vaccine Immunology : CVI|October 13, 2017
Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization AssayCindy Shambaugh, Sarieh Azshirvani, Li Yu, et al.
Journal of Medical Virology|August 23, 2018
Respiratory syncytial virus-associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive heart failureAnn R Falsey, Edward E Walsh, Mark T Esser, et al.
Clinical and Vaccine Immunology : CVI|December 15, 2012
Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion proteinAnu Cherukuri, Kathryn Patton, Robert A Gasser, et al.
Scientific Reports|March 9, 2019
Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015-17Bin Lu, Hui Liu, David E Tabor, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Journal of Immunological Methods|February 2, 2006
A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheresSonela A Schlottmann, Neil Jain, Narendra Chirmule, et al.
The Lancet. Respiratory Medicine|December 15, 2022
Cardiac and vascular serious adverse events following tixagevimab-cilgavimab - Author's replySheetal Maselkar, Alexandre Kiazand, Alison Templeton, et al.
Human Vaccines & Immunotherapeutics|June 19, 2018
Generalized ROC methods for immunogenicity data analysis of vaccine phase I studies in a seropositive populationLi Yu, Mark T Esser, Judith Falloon, et al.
Journal of Immune Based Therapies and Vaccines|April 22, 2005
Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvantWanda Ruiz, William L McClements, Kathrin U Jansen, et al.
Expert Review of Vaccines|May 21, 2017
Passive and active immunization against respiratory syncytial virus for the young and oldTonya Villafana, Judith Falloon, M Pamela Griffin, et al.
Human Vaccines|April 5, 2008
Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11Judith F Smith, Rose Kowalski, Mark T Esser, et al.
Clinical and Vaccine Immunology : CVI|October 13, 2017
Development of a High-Throughput Respiratory Syncytial Virus Fluorescent Focus-Based Microneutralization AssayCindy Shambaugh, Sarieh Azshirvani, Li Yu, et al.
Journal of Medical Virology|August 23, 2018
Respiratory syncytial virus-associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive heart failureAnn R Falsey, Edward E Walsh, Mark T Esser, et al.
Clinical and Vaccine Immunology : CVI|December 15, 2012
Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion proteinAnu Cherukuri, Kathryn Patton, Robert A Gasser, et al.
Scientific Reports|March 9, 2019
Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015-17Bin Lu, Hui Liu, David E Tabor, et al.
Pageof 10